share_log

我武生物(300357.SZ):烟曲霉点刺液I期临床试验首例受试者入组

Wawu Biotech (300357.SZ): The first subject of the phase I clinical trial of Aspergillus fumigerum prick was enrolled

Zhitong Finance ·  Sep 18, 2023 04:38

Zhitong Financial APP, 300357.SZ announced that the company's research and development of "Aspergillus fumigatus puncturing liquid" in Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology completed "a clinical study on the safety and efficacy of Aspergillus fumigatus puncturing fluid among Chinese volunteers-a single-center, open phase I clinical study" and officially entered the clinical trial. It is reported that the drug is used in skin prick test to assist in the diagnosis of type I allergic diseases caused by Aspergillus fumigatus.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment